5 Stocks with Strengthening Financials
When AIG's CEO, Edward Liddy, testified before Congress last week, we took a look back at the company's historical quarterly financials to identify when the proverbial "writing on the wall" could have been first seen (read the full story here).
Now, using the same proprietary CNBC tool that looks for statistical patterns in a company's financials, we screened for companies with market caps of ~$1 billion or more and that have accelerating performance in key financial metrics. The model scores companies based on the rate of change in key metrics for growth, liquidity and profitability on a quarterly, trailing twelve month and 3-year basis. An overall score is determined based on the strength of the three underlying scores. The scores are reflected on a green-to-red color scale, darker red indicates a rapidly worsening condition, darker green indicates rapidly improving conditions. The example below depicts a company that would have a very strong overall score because of its high underlying scores.
Keep in mind that the results of this screen are based on trends from reported SEC filings and that trends may change in the future. Nonetheless, here are 5 companies that scored highly and the details for where they outperform.
Myriad Genetics is a biotech company with a $3.8 billion market cap. On a year-to-date basis, its stock is up ~23%.
Looking back at its past 5 quarters, you can see that the company has improved in its growth and profitability scores.
Peeling the onion back on these scores, you can see that they are driven by margins that were growing at an accelerating rate, particularly in Q4 and Q1 of its fiscal 2008 and 2009. For the most recent quarter, the underlying metrics are still outperforming their historical averages but have slowed a bit (dark green shifting to lighter green).
On a forward looking basis, Thomson Reuters data shows consensus EPS estimates growing at 84% for the next fiscal year.